Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma
- Autores
- Croci, D.O.; Salatino, M.; Rubinstein, N.; Cerliani, J.P.; Cavallin, L.E.; Leung, H.J.; Ouyang, J.; Ilarregui, J.M.; Toscano, M.A.; Domaica, C.I.; Croci, M.C.; Shipp, M.A.; Mesri, E.A.; Albini, A.; Rabinovich, G.A.
- Año de publicación
- 2012
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Kaposi's sarcoma (KS), a multifocal vascular neoplasm linked to human herpesvirus-8 (HHV-8/KS-associated herpesvirus [KSHV]) infection, is the most common AIDS-associated malignancy. Clinical management of KS has proven to be challenging because of its prevalence in immunosuppressed patients and its unique vascular and inflammatory nature that is sustained by viral and host-derived paracrine-acting factors primarily released under hypoxic conditions. We show that interactions between the regulatory lectin galectin-1 (Gal-1) and specific target N-glycans link tumor hypoxia to neovascularization as part of the pathogenesis of KS. Expression of Gal-1 is found to be a hallmark of human KS but not other vascular pathologies and is directly induced by both KSHV and hypoxia. Interestingly, hypoxia induced Gal-1 through mechanisms that are independent of hypoxia-inducible factor (HIF) 1α and HIF-2α but involved reactive oxygen species-dependent activation of the transcription factor nuclear factor κB. Targeted disruption of Gal-1-N-glycan interactions eliminated hypoxia-driven angiogenesis and suppressed tumorigenesis in vivo. Therapeutic administration of a Gal-1-specific neutralizing mAb attenuated abnormal angiogenesis and promoted tumor regression in mice bearing established KS tumors. Given the active search for HIF-independent mechanisms that serve to couple tumor hypoxia to pathological angiogenesis, our findings provide novel opportunities not only for treating KS patients but also for understanding and managing a variety of solid tumors. © 2012 Croci et al.
Fil:Croci, D.O. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina.
Fil:Salatino, M. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina.
Fil:Rubinstein, N. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina.
Fil:Ilarregui, J.M. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina.
Fil:Toscano, M.A. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina.
Fil:Domaica, C.I. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina.
Fil:Mesri, E.A. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. - Fuente
- J. Exp. Med. 2012;209(11):1985-2000
- Materia
-
galectin 1
glycan
hypoxia inducible factor 1alpha
hypoxia inducible factor 2alpha
immunoglobulin enhancer binding protein
messenger RNA
monoclonal antibody
reactive oxygen metabolite
angiogenesis
animal cell
animal experiment
animal model
animal tissue
apoptosis
article
carcinogenesis
cell growth
cell invasion
cell migration
cell proliferation
controlled study
human
human cell
human tissue
hypoxia
in vivo study
Kaposi sarcoma
male
mouse
nonhuman
priority journal
protein expression
protein function
protein protein interaction
protein targeting
spindle cell
tumor regression
Animals
Anoxia
Antibodies, Monoclonal
Antibodies, Neutralizing
Cell Hypoxia
Cell Line, Tumor
Cells, Cultured
Galectin 1
Gene Expression Regulation, Neoplastic
HEK293 Cells
Herpesvirus 8, Human
Host-Pathogen Interactions
Humans
Immunoblotting
Mice
Mice, Inbred C57BL
Mice, Knockout
Mice, Nude
Neovascularization, Pathologic
Polysaccharides
Protein Binding
Reverse Transcriptase Polymerase Chain Reaction
RNA Interference
Sarcoma, Kaposi
Xenograft Model Antitumor Assays - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- http://creativecommons.org/licenses/by/2.5/ar
- Repositorio
- Institución
- Universidad Nacional de Buenos Aires. Facultad de Ciencias Exactas y Naturales
- OAI Identificador
- paperaa:paper_00221007_v209_n11_p1985_Croci
Ver los metadatos del registro completo
id |
BDUBAFCEN_01f9c459cd456ae07cecee5d85240ce5 |
---|---|
oai_identifier_str |
paperaa:paper_00221007_v209_n11_p1985_Croci |
network_acronym_str |
BDUBAFCEN |
repository_id_str |
1896 |
network_name_str |
Biblioteca Digital (UBA-FCEN) |
spelling |
Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcomaCroci, D.O.Salatino, M.Rubinstein, N.Cerliani, J.P.Cavallin, L.E.Leung, H.J.Ouyang, J.Ilarregui, J.M.Toscano, M.A.Domaica, C.I.Croci, M.C.Shipp, M.A.Mesri, E.A.Albini, A.Rabinovich, G.A.galectin 1glycanhypoxia inducible factor 1alphahypoxia inducible factor 2alphaimmunoglobulin enhancer binding proteinmessenger RNAmonoclonal antibodyreactive oxygen metaboliteangiogenesisanimal cellanimal experimentanimal modelanimal tissueapoptosisarticlecarcinogenesiscell growthcell invasioncell migrationcell proliferationcontrolled studyhumanhuman cellhuman tissuehypoxiain vivo studyKaposi sarcomamalemousenonhumanpriority journalprotein expressionprotein functionprotein protein interactionprotein targetingspindle celltumor regressionAnimalsAnoxiaAntibodies, MonoclonalAntibodies, NeutralizingCell HypoxiaCell Line, TumorCells, CulturedGalectin 1Gene Expression Regulation, NeoplasticHEK293 CellsHerpesvirus 8, HumanHost-Pathogen InteractionsHumansImmunoblottingMiceMice, Inbred C57BLMice, KnockoutMice, NudeNeovascularization, PathologicPolysaccharidesProtein BindingReverse Transcriptase Polymerase Chain ReactionRNA InterferenceSarcoma, KaposiXenograft Model Antitumor AssaysKaposi's sarcoma (KS), a multifocal vascular neoplasm linked to human herpesvirus-8 (HHV-8/KS-associated herpesvirus [KSHV]) infection, is the most common AIDS-associated malignancy. Clinical management of KS has proven to be challenging because of its prevalence in immunosuppressed patients and its unique vascular and inflammatory nature that is sustained by viral and host-derived paracrine-acting factors primarily released under hypoxic conditions. We show that interactions between the regulatory lectin galectin-1 (Gal-1) and specific target N-glycans link tumor hypoxia to neovascularization as part of the pathogenesis of KS. Expression of Gal-1 is found to be a hallmark of human KS but not other vascular pathologies and is directly induced by both KSHV and hypoxia. Interestingly, hypoxia induced Gal-1 through mechanisms that are independent of hypoxia-inducible factor (HIF) 1α and HIF-2α but involved reactive oxygen species-dependent activation of the transcription factor nuclear factor κB. Targeted disruption of Gal-1-N-glycan interactions eliminated hypoxia-driven angiogenesis and suppressed tumorigenesis in vivo. Therapeutic administration of a Gal-1-specific neutralizing mAb attenuated abnormal angiogenesis and promoted tumor regression in mice bearing established KS tumors. Given the active search for HIF-independent mechanisms that serve to couple tumor hypoxia to pathological angiogenesis, our findings provide novel opportunities not only for treating KS patients but also for understanding and managing a variety of solid tumors. © 2012 Croci et al.Fil:Croci, D.O. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina.Fil:Salatino, M. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina.Fil:Rubinstein, N. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina.Fil:Ilarregui, J.M. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina.Fil:Toscano, M.A. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina.Fil:Domaica, C.I. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina.Fil:Mesri, E.A. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina.2012info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfhttp://hdl.handle.net/20.500.12110/paper_00221007_v209_n11_p1985_CrociJ. Exp. Med. 2012;209(11):1985-2000reponame:Biblioteca Digital (UBA-FCEN)instname:Universidad Nacional de Buenos Aires. Facultad de Ciencias Exactas y Naturalesinstacron:UBA-FCENenginfo:eu-repo/semantics/openAccesshttp://creativecommons.org/licenses/by/2.5/ar2025-09-04T09:48:47Zpaperaa:paper_00221007_v209_n11_p1985_CrociInstitucionalhttps://digital.bl.fcen.uba.ar/Universidad públicaNo correspondehttps://digital.bl.fcen.uba.ar/cgi-bin/oaiserver.cgiana@bl.fcen.uba.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:18962025-09-04 09:48:49.372Biblioteca Digital (UBA-FCEN) - Universidad Nacional de Buenos Aires. Facultad de Ciencias Exactas y Naturalesfalse |
dc.title.none.fl_str_mv |
Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma |
title |
Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma |
spellingShingle |
Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma Croci, D.O. galectin 1 glycan hypoxia inducible factor 1alpha hypoxia inducible factor 2alpha immunoglobulin enhancer binding protein messenger RNA monoclonal antibody reactive oxygen metabolite angiogenesis animal cell animal experiment animal model animal tissue apoptosis article carcinogenesis cell growth cell invasion cell migration cell proliferation controlled study human human cell human tissue hypoxia in vivo study Kaposi sarcoma male mouse nonhuman priority journal protein expression protein function protein protein interaction protein targeting spindle cell tumor regression Animals Anoxia Antibodies, Monoclonal Antibodies, Neutralizing Cell Hypoxia Cell Line, Tumor Cells, Cultured Galectin 1 Gene Expression Regulation, Neoplastic HEK293 Cells Herpesvirus 8, Human Host-Pathogen Interactions Humans Immunoblotting Mice Mice, Inbred C57BL Mice, Knockout Mice, Nude Neovascularization, Pathologic Polysaccharides Protein Binding Reverse Transcriptase Polymerase Chain Reaction RNA Interference Sarcoma, Kaposi Xenograft Model Antitumor Assays |
title_short |
Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma |
title_full |
Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma |
title_fullStr |
Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma |
title_full_unstemmed |
Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma |
title_sort |
Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma |
dc.creator.none.fl_str_mv |
Croci, D.O. Salatino, M. Rubinstein, N. Cerliani, J.P. Cavallin, L.E. Leung, H.J. Ouyang, J. Ilarregui, J.M. Toscano, M.A. Domaica, C.I. Croci, M.C. Shipp, M.A. Mesri, E.A. Albini, A. Rabinovich, G.A. |
author |
Croci, D.O. |
author_facet |
Croci, D.O. Salatino, M. Rubinstein, N. Cerliani, J.P. Cavallin, L.E. Leung, H.J. Ouyang, J. Ilarregui, J.M. Toscano, M.A. Domaica, C.I. Croci, M.C. Shipp, M.A. Mesri, E.A. Albini, A. Rabinovich, G.A. |
author_role |
author |
author2 |
Salatino, M. Rubinstein, N. Cerliani, J.P. Cavallin, L.E. Leung, H.J. Ouyang, J. Ilarregui, J.M. Toscano, M.A. Domaica, C.I. Croci, M.C. Shipp, M.A. Mesri, E.A. Albini, A. Rabinovich, G.A. |
author2_role |
author author author author author author author author author author author author author author |
dc.subject.none.fl_str_mv |
galectin 1 glycan hypoxia inducible factor 1alpha hypoxia inducible factor 2alpha immunoglobulin enhancer binding protein messenger RNA monoclonal antibody reactive oxygen metabolite angiogenesis animal cell animal experiment animal model animal tissue apoptosis article carcinogenesis cell growth cell invasion cell migration cell proliferation controlled study human human cell human tissue hypoxia in vivo study Kaposi sarcoma male mouse nonhuman priority journal protein expression protein function protein protein interaction protein targeting spindle cell tumor regression Animals Anoxia Antibodies, Monoclonal Antibodies, Neutralizing Cell Hypoxia Cell Line, Tumor Cells, Cultured Galectin 1 Gene Expression Regulation, Neoplastic HEK293 Cells Herpesvirus 8, Human Host-Pathogen Interactions Humans Immunoblotting Mice Mice, Inbred C57BL Mice, Knockout Mice, Nude Neovascularization, Pathologic Polysaccharides Protein Binding Reverse Transcriptase Polymerase Chain Reaction RNA Interference Sarcoma, Kaposi Xenograft Model Antitumor Assays |
topic |
galectin 1 glycan hypoxia inducible factor 1alpha hypoxia inducible factor 2alpha immunoglobulin enhancer binding protein messenger RNA monoclonal antibody reactive oxygen metabolite angiogenesis animal cell animal experiment animal model animal tissue apoptosis article carcinogenesis cell growth cell invasion cell migration cell proliferation controlled study human human cell human tissue hypoxia in vivo study Kaposi sarcoma male mouse nonhuman priority journal protein expression protein function protein protein interaction protein targeting spindle cell tumor regression Animals Anoxia Antibodies, Monoclonal Antibodies, Neutralizing Cell Hypoxia Cell Line, Tumor Cells, Cultured Galectin 1 Gene Expression Regulation, Neoplastic HEK293 Cells Herpesvirus 8, Human Host-Pathogen Interactions Humans Immunoblotting Mice Mice, Inbred C57BL Mice, Knockout Mice, Nude Neovascularization, Pathologic Polysaccharides Protein Binding Reverse Transcriptase Polymerase Chain Reaction RNA Interference Sarcoma, Kaposi Xenograft Model Antitumor Assays |
dc.description.none.fl_txt_mv |
Kaposi's sarcoma (KS), a multifocal vascular neoplasm linked to human herpesvirus-8 (HHV-8/KS-associated herpesvirus [KSHV]) infection, is the most common AIDS-associated malignancy. Clinical management of KS has proven to be challenging because of its prevalence in immunosuppressed patients and its unique vascular and inflammatory nature that is sustained by viral and host-derived paracrine-acting factors primarily released under hypoxic conditions. We show that interactions between the regulatory lectin galectin-1 (Gal-1) and specific target N-glycans link tumor hypoxia to neovascularization as part of the pathogenesis of KS. Expression of Gal-1 is found to be a hallmark of human KS but not other vascular pathologies and is directly induced by both KSHV and hypoxia. Interestingly, hypoxia induced Gal-1 through mechanisms that are independent of hypoxia-inducible factor (HIF) 1α and HIF-2α but involved reactive oxygen species-dependent activation of the transcription factor nuclear factor κB. Targeted disruption of Gal-1-N-glycan interactions eliminated hypoxia-driven angiogenesis and suppressed tumorigenesis in vivo. Therapeutic administration of a Gal-1-specific neutralizing mAb attenuated abnormal angiogenesis and promoted tumor regression in mice bearing established KS tumors. Given the active search for HIF-independent mechanisms that serve to couple tumor hypoxia to pathological angiogenesis, our findings provide novel opportunities not only for treating KS patients but also for understanding and managing a variety of solid tumors. © 2012 Croci et al. Fil:Croci, D.O. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Salatino, M. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Rubinstein, N. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Ilarregui, J.M. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Toscano, M.A. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Domaica, C.I. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Mesri, E.A. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. |
description |
Kaposi's sarcoma (KS), a multifocal vascular neoplasm linked to human herpesvirus-8 (HHV-8/KS-associated herpesvirus [KSHV]) infection, is the most common AIDS-associated malignancy. Clinical management of KS has proven to be challenging because of its prevalence in immunosuppressed patients and its unique vascular and inflammatory nature that is sustained by viral and host-derived paracrine-acting factors primarily released under hypoxic conditions. We show that interactions between the regulatory lectin galectin-1 (Gal-1) and specific target N-glycans link tumor hypoxia to neovascularization as part of the pathogenesis of KS. Expression of Gal-1 is found to be a hallmark of human KS but not other vascular pathologies and is directly induced by both KSHV and hypoxia. Interestingly, hypoxia induced Gal-1 through mechanisms that are independent of hypoxia-inducible factor (HIF) 1α and HIF-2α but involved reactive oxygen species-dependent activation of the transcription factor nuclear factor κB. Targeted disruption of Gal-1-N-glycan interactions eliminated hypoxia-driven angiogenesis and suppressed tumorigenesis in vivo. Therapeutic administration of a Gal-1-specific neutralizing mAb attenuated abnormal angiogenesis and promoted tumor regression in mice bearing established KS tumors. Given the active search for HIF-independent mechanisms that serve to couple tumor hypoxia to pathological angiogenesis, our findings provide novel opportunities not only for treating KS patients but also for understanding and managing a variety of solid tumors. © 2012 Croci et al. |
publishDate |
2012 |
dc.date.none.fl_str_mv |
2012 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/20.500.12110/paper_00221007_v209_n11_p1985_Croci |
url |
http://hdl.handle.net/20.500.12110/paper_00221007_v209_n11_p1985_Croci |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/2.5/ar |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
http://creativecommons.org/licenses/by/2.5/ar |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
J. Exp. Med. 2012;209(11):1985-2000 reponame:Biblioteca Digital (UBA-FCEN) instname:Universidad Nacional de Buenos Aires. Facultad de Ciencias Exactas y Naturales instacron:UBA-FCEN |
reponame_str |
Biblioteca Digital (UBA-FCEN) |
collection |
Biblioteca Digital (UBA-FCEN) |
instname_str |
Universidad Nacional de Buenos Aires. Facultad de Ciencias Exactas y Naturales |
instacron_str |
UBA-FCEN |
institution |
UBA-FCEN |
repository.name.fl_str_mv |
Biblioteca Digital (UBA-FCEN) - Universidad Nacional de Buenos Aires. Facultad de Ciencias Exactas y Naturales |
repository.mail.fl_str_mv |
ana@bl.fcen.uba.ar |
_version_ |
1842340708234559488 |
score |
12.623145 |